The preventable burden of breast cancers for premenopausal and postmenopausal women in Australia: A pooled cohort study

Maria E Arriaga¹, Claire M Vajdic¹, Karen Canfell^{2

3

4}, Robert J MacInnis^{5

6}, Emily Banks⁷, Julie E Byles⁸, Dianna J Magliano⁹, Anne W Taylor¹⁰, Paul Mitchell¹¹, Graham G Giles^{5

6}, Jonathan E Shaw¹², Tiffany K Gill¹⁰, Elizabeth Klaes¹³, Louiza S Velentzis^{2

6}, Robert G Cumming^{3

14}, Vasant Hirani^{3

15}, Maarit A Laaksonen¹

Affiliations

¹ Centre for Big Data Research in Health, University of New South Wales, Sydney, Australia.
² Cancer Research Division, Cancer Council New South Wales, Sydney, Australia.
³ Faculty of Medicine and Health, School of Public Health, University of Sydney, Sydney, Australia.
⁴ Prince of Wales Clinical School, University of New South Wales, Sydney, Australia.
⁵ Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia.
⁶ Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
⁷ ANU College of Medicine, Biology and Environment, Australian National University, Canberra, Australia.
⁸ Research Centre for Gender, Health and Ageing, University of Newcastle, Newcastle, Australia.
⁹ Diabetes and Population Health Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.
¹⁰ Adelaide Medical School, University of Adelaide, Adelaide, Australia.
¹¹ Centre for Vision Research, Westmead Institute for Medical research, University of Sydney, Sydney, Australia.
¹² Clinical Diabetes Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.
¹³ Breast Cancer Network Australia, Melbourne, Australia.
¹⁴ ANZAC Research Institute, University of Sydney and Concord Hospital, Sydney, Australia.
¹⁵ School of Life and Environmental Sciences Charles Perkins Centre, University of Sydney, Sydney, Australia.

PMID: 30802946
DOI: 10.1002/ijc.32231

The preventable burden of breast cancers for premenopausal and postmenopausal women in Australia: A pooled cohort study

Maria E Arriaga et al. Int J Cancer. 2019.

. 2019 Nov 1;145(9):2383-2394.

doi: 10.1002/ijc.32231. Epub 2019 Mar 18.

Authors

Affiliations

¹ Centre for Big Data Research in Health, University of New South Wales, Sydney, Australia.
² Cancer Research Division, Cancer Council New South Wales, Sydney, Australia.
³ Faculty of Medicine and Health, School of Public Health, University of Sydney, Sydney, Australia.
⁴ Prince of Wales Clinical School, University of New South Wales, Sydney, Australia.
⁵ Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia.
⁶ Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
⁷ ANU College of Medicine, Biology and Environment, Australian National University, Canberra, Australia.
⁸ Research Centre for Gender, Health and Ageing, University of Newcastle, Newcastle, Australia.
⁹ Diabetes and Population Health Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.
¹⁰ Adelaide Medical School, University of Adelaide, Adelaide, Australia.
¹¹ Centre for Vision Research, Westmead Institute for Medical research, University of Sydney, Sydney, Australia.
¹² Clinical Diabetes Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.
¹³ Breast Cancer Network Australia, Melbourne, Australia.
¹⁴ ANZAC Research Institute, University of Sydney and Concord Hospital, Sydney, Australia.
¹⁵ School of Life and Environmental Sciences Charles Perkins Centre, University of Sydney, Sydney, Australia.

PMID: 30802946
DOI: 10.1002/ijc.32231

Abstract

Estimates of the future breast cancer burden preventable through modifications to current behaviours are lacking. We assessed the effect of individual and joint behaviour modifications on breast cancer burden for premenopausal and postmenopausal Australian women, and whether effects differed between population subgroups. We linked pooled data from six Australian cohort studies (n = 214,536) to national cancer and death registries, and estimated the strength of the associations between behaviours causally related to cancer incidence and death using adjusted proportional hazards models. We estimated exposure prevalence from representative health surveys. We combined these estimates to calculate Population Attributable Fractions (PAFs) with 95% confidence intervals (CIs), and compared PAFs for population subgroups. During the first 10 years follow-up, there were 640 incident breast cancers for premenopausal women, 2,632 for postmenopausal women, and 8,761 deaths from any cause. Of future breast cancers for premenopausal women, any regular alcohol consumption explains 12.6% (CI = 4.3-20.2%), current use of oral contraceptives for ≥5 years 7.1% (CI = 0.3-13.5%), and these factors combined 18.8% (CI = 9.1-27.4%). Of future breast cancers for postmenopausal women, overweight or obesity (BMI ≥25 kg/m² ) explains 12.8% (CI = 7.8-17.5%), current use of menopausal hormone therapy (MHT) 6.9% (CI = 4.8-8.9%), any regular alcohol consumption 6.6% (CI = 1.5-11.4%), and these factors combined 24.2% (CI = 17.6-30.3%). The MHT-related postmenopausal breast cancer burden varied by body fatness, alcohol consumption and socio-economic status, the body fatness-related postmenopausal breast cancer burden by alcohol consumption and educational attainment, and the alcohol-related postmenopausal breast cancer burden by breast feeding history. Our results provide evidence to support targeted and population-level cancer control activities.

Keywords: breast cancer; cohort; population attributable fraction; preventable burden; risk factors.

PubMed Disclaimer

References

1. World Cancer Research Fund/American Institute for Cancer Research. Continuous update project report. Diet, nutrition, physical activity and breast cancer. Washington, DC: AICR, 2017 Available at: https://www.wcrf.org/sites/default/files/Breast-cancer-report.pdf, accessed 27 September 2018.
1. Australian Institute of Health and Welfare. Cancer in Australia 2017 Cancer series No. 101. Cat. no. CAN 100. Canberra: AIHW, 2017 Available at: https://www.aihw.gov.au/getmedia/3da1f3c2-30f0-4475-8aed-1f19f8e16d48/20..., accessed 27 September 2018.
1. International Agency for Research on Cancer. Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 91. Lyon: IARC, 2007 Available at: https://monographs.iarc.fr/ENG/Monographs/vol91/mono91.pdf, accessed 27 September 2018.
1. International Agency for Research on Cancer. Pharmaceuticals. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 100A. Lyon: IARC, 2012 Available at: http://monographs.iarc.fr/ENG/Monographs/vol100A/mono100A.pdf, accessed 27 September 2018.
1. Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body fatness and cancer - viewpoint of the IARC working group. N Engl J Med 2016;375:794-8.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The preventable burden of breast cancers for premenopausal and postmenopausal women in Australia: A pooled cohort study

Affiliations

The preventable burden of breast cancers for premenopausal and postmenopausal women in Australia: A pooled cohort study

Authors

Affiliations

Abstract

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical